Skip to main content

Blog

WATCH: Solid Biosciences – Update on Gene Therapy Candidate SGT-003 (Webinar Recording)

...

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

...

Solid Biosciences Shares Initial Data from INSPIRE DUCHENNE Study of Gene Therapy Candidate SGT-003

...

Cumberland Pharmaceuticals Announces Positive Results from Phase 2 FIGHT DMD Trial of Ifetroban for Treatment of Duchenne Cardiomyopathy

...

Sarepta Therapeutics Announces Results from Part 2 of EMBARK Study of ELEVIDYS

...

Update from PPMD’s 2025 Duchenne Healthcare Professionals Summit

...

Race to End Duchenne Kicks Off 20th Anniversary at Walt Disney World Marathon Weekend

...

PPMD Advocacy in the 119th Congress and the 47th Administration

...

Advance the Research Evolution with The Duchenne Registry

...

PPMD Hosts 2025 Duchenne Healthcare Professionals Summit in San Diego, California

...